241 related articles for article (PubMed ID: 9056668)
1. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
Han NM; Curley SA; Gallick GE
Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
[TBL] [Abstract][Full Text] [Related]
3. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
4. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
5. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase.
Fleming RY; Ellis LM; Parikh NU; Liu W; Staley CA; Gallick GE
Surgery; 1997 Aug; 122(2):501-7. PubMed ID: 9288158
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
7. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
8. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
9. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
Zhu S; Bjorge JD; Cheng HC; Fujita DJ
Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
[TBL] [Abstract][Full Text] [Related]
10. Expression of C-terminal src kinase in human colorectal cancer cell lines.
Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.
Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ
Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417
[TBL] [Abstract][Full Text] [Related]
12. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Garcia R; Parikh NU; Saya H; Gallick GE
Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract][Full Text] [Related]
16. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.
Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH
Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
[TBL] [Abstract][Full Text] [Related]
19. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
[TBL] [Abstract][Full Text] [Related]
20. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
Brunton VG; Ozanne BW; Paraskeva C; Frame MC
Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]